Li, Xue
Blais, Joseph E.
Wong, Ian C. K.
Tam, Anthony W. Y.
Cowling, Benjamin J.
Hung, Ivan F. N.
Chan, Esther W. Y.
Funding for this research was provided by:
Pfizer Corporation Hong Kong Limited (WI214458)
Article History
Received: 19 October 2018
Accepted: 17 December 2018
First Online: 25 January 2019
Compliance with ethical standards
:
: The study was approved by the Institutional Review Board of The University of Hong Kong/Hospital Authority Hong Kong West Cluster (reference number: UW16-327). Informed patient consent was waived as the data used in this study were de-identified.
: Not applicable.
: EWC has received the Early Career Scheme and the General Research Fund from the Hong Kong Research Grants Council; Health and Medical Research Fund from the Food and Health Bureau of Hong Kong; internal funding from The University of Hong Kong; and research funding from Bristol-Myers Squibb, Pfizer, and Janssen, all unrelated to the current work. BJC has received research funding from Sanofi Pasteur and consulting fees from Roche, all unrelated to the current work. The other co-authors declare that they have no conflict of interest.